Sartorius AG (SRT3)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

€229.40

Buy

€231.00

arrow-up€0.80 (+0.35%)

Prices updated at 12 Jun 2026, 16:36 CEST

Prices minimum 15 mins delay

Prices in EUR

Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and servic ...

FTSE EuroFirst 300

1.88%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Dietmar Muller

CEO

-

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

14,242

Head office

Otto-Brenner-Strasse 20

Gottingen

Germany

37079

+49 5513080

info@sartorius.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Professor Dr. David Raymond Ebsworth, PhD Member of the Supervisory Board	-
Professor Dr. Klaus Ruediger Trutzschler Member of the Supervisory Board	-
Dr. Lothar Kappich Chairman of the Supervisory Board	-
Ms. Annette Becker Member of the Supervisory Board	-
Dr. Daniela Favoccia Member of the Supervisory Board	-
Mr. Dietmar Muller Deputy Chairman of the Supervisory Board	-
Ms. Ilke Hildegard Panzer Member of the Supervisory Board	-
Mr. Hermann Jens Ritzau Member of the Supervisory Board	-
Mr. Frank Riemensperger Member of the Supervisory Board	-
Ms. Sabrina Wirth Member of the Supervisory Board	-
Ms. Beatrix Henseler Member of the Supervisory Board	-
Mr. Dominik Langosch Member of the Supervisory Board	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard	1,579,227
Vanguard International Growth Fund	1,464,592
Union Investment Privatfonds GmbH	646,899
Fidelity Management & Research Company LLC	524,142
BlackRock Fund Advisors	490,842

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.